nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapiprazole—ADRA1D—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.0629	0.0629	CbGpPWpGaD
Dapiprazole—ADRA1B—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.0522	0.0522	CbGpPWpGaD
Dapiprazole—ADRA1D—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.0509	0.0509	CbGpPWpGaD
Dapiprazole—ADRA1A—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.0463	0.0463	CbGpPWpGaD
Dapiprazole—ADRA1B—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.0423	0.0423	CbGpPWpGaD
Dapiprazole—ADRA1A—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.0376	0.0376	CbGpPWpGaD
Dapiprazole—ADRA1D—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0222	0.0222	CbGpPWpGaD
Dapiprazole—ADRA1D—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0187	0.0187	CbGpPWpGaD
Dapiprazole—ADRA1B—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0185	0.0185	CbGpPWpGaD
Dapiprazole—ADRA1D—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.018	0.018	CbGpPWpGaD
Dapiprazole—ADRA1A—Endothelin Pathways—ADRB1—dilated cardiomyopathy	0.0164	0.0164	CbGpPWpGaD
Dapiprazole—ADRA1A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0164	0.0164	CbGpPWpGaD
Dapiprazole—ADRA1B—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0155	0.0155	CbGpPWpGaD
Dapiprazole—ADRA1D—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0151	0.0151	CbGpPWpGaD
Dapiprazole—ADRA1B—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.015	0.015	CbGpPWpGaD
Dapiprazole—ADRA1D—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.0141	0.0141	CbGpPWpGaD
Dapiprazole—ADRA1A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0138	0.0138	CbGpPWpGaD
Dapiprazole—ADRA1D—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.0137	0.0137	CbGpPWpGaD
Dapiprazole—ADRA1A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0133	0.0133	CbGpPWpGaD
Dapiprazole—ADRA1B—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0126	0.0126	CbGpPWpGaD
Dapiprazole—ADRA1B—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.0117	0.0117	CbGpPWpGaD
Dapiprazole—ADRA1B—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.0114	0.0114	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0113	0.0113	CbGpPWpGaD
Dapiprazole—ADRA1A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0112	0.0112	CbGpPWpGaD
Dapiprazole—ADRA1A—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.0104	0.0104	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.0102	0.0102	CbGpPWpGaD
Dapiprazole—ADRA1A—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.0101	0.0101	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00942	0.00942	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00837	0.00837	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.008	0.008	CbGpPWpGaD
Dapiprazole—ADRA1D—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.00725	0.00725	CbGpPWpGaD
Dapiprazole—ADRA1B—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.00712	0.00712	CbGpPWpGaD
Dapiprazole—ADRA1A—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.00684	0.00684	CbGpPWpGaD
Dapiprazole—ADRA1B—LPA receptor mediated events—RAC1—dilated cardiomyopathy	0.00683	0.00683	CbGpPWpGaD
Dapiprazole—ADRA1D—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00666	0.00666	CbGpPWpGaD
Dapiprazole—ADRA1A—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.00633	0.00633	CbGpPWpGaD
Dapiprazole—ADRA1B—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.00602	0.00602	CbGpPWpGaD
Dapiprazole—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00552	0.00552	CbGpPWpGaD
Dapiprazole—ADRA1D—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00549	0.00549	CbGpPWpGaD
Dapiprazole—ADRA1D—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00539	0.00539	CbGpPWpGaD
Dapiprazole—ADRA1A—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.00535	0.00535	CbGpPWpGaD
Dapiprazole—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00491	0.00491	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00477	0.00477	CbGpPWpGaD
Dapiprazole—ADRA1D—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00474	0.00474	CbGpPWpGaD
Dapiprazole—ADRA1B—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00456	0.00456	CbGpPWpGaD
Dapiprazole—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00448	0.00448	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00443	0.00443	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00429	0.00429	CbGpPWpGaD
Dapiprazole—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00424	0.00424	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00408	0.00408	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00408	0.00408	CbGpPWpGaD
Dapiprazole—ADRA1A—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00405	0.00405	CbGpPWpGaD
Dapiprazole—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00398	0.00398	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00395	0.00395	CbGpPWpGaD
Dapiprazole—ADRA1B—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00393	0.00393	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0038	0.0038	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00368	0.00368	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00368	0.00368	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00366	0.00366	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00356	0.00356	CbGpPWpGaD
Dapiprazole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00352	0.00352	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00351	0.00351	CbGpPWpGaD
Dapiprazole—ADRA1A—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00349	0.00349	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00348	0.00348	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00339	0.00339	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00339	0.00339	CbGpPWpGaD
Dapiprazole—ADRA1D—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00334	0.00334	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00327	0.00327	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00316	0.00316	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00315	0.00315	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00314	0.00314	CbGpPWpGaD
Dapiprazole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00313	0.00313	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00311	0.00311	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00311	0.00311	CbGpPWpGaD
Dapiprazole—ADRA1B—LPA receptor mediated events—EGFR—dilated cardiomyopathy	0.00311	0.00311	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00305	0.00305	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00304	0.00304	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00301	0.00301	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00301	0.00301	CbGpPWpGaD
Dapiprazole—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00298	0.00298	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00298	0.00298	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00289	0.00289	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00289	0.00289	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0028	0.0028	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0028	0.0028	CbGpPWpGaD
Dapiprazole—ADRA1B—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00277	0.00277	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00271	0.00271	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.0027	0.0027	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00261	0.00261	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00258	0.00258	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00258	0.00258	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00256	0.00256	CbGpPWpGaD
Dapiprazole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00248	0.00248	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00247	0.00247	CbGpPWpGaD
Dapiprazole—ADRA1A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00246	0.00246	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0024	0.0024	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00239	0.00239	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00232	0.00232	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00231	0.00231	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00229	0.00229	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00229	0.00229	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00227	0.00227	CbGpPWpGaD
Dapiprazole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00221	0.00221	CbGpPWpGaD
Dapiprazole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.0022	0.0022	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.0022	0.0022	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00213	0.00213	CbGpPWpGaD
Dapiprazole—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00207	0.00207	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00206	0.00206	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00198	0.00198	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00188	0.00188	CbGpPWpGaD
Dapiprazole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00183	0.00183	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00176	0.00176	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00176	0.00176	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00176	0.00176	CbGpPWpGaD
Dapiprazole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00172	0.00172	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00168	0.00168	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00167	0.00167	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00163	0.00163	CbGpPWpGaD
Dapiprazole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00163	0.00163	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.0016	0.0016	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.0016	0.0016	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00158	0.00158	CbGpPWpGaD
Dapiprazole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00153	0.00153	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00148	0.00148	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00146	0.00146	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00146	0.00146	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00144	0.00144	CbGpPWpGaD
Dapiprazole—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00142	0.00142	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.0014	0.0014	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00136	0.00136	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00135	0.00135	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00132	0.00132	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00132	0.00132	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00131	0.00131	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.0013	0.0013	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.0013	0.0013	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00128	0.00128	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00124	0.00124	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00123	0.00123	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00123	0.00123	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.0012	0.0012	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00119	0.00119	CbGpPWpGaD
Dapiprazole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00118	0.00118	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00118	0.00118	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00118	0.00118	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00117	0.00117	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00116	0.00116	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00112	0.00112	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00109	0.00109	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00106	0.00106	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00106	0.00106	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00106	0.00106	CbGpPWpGaD
Dapiprazole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00105	0.00105	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00102	0.00102	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000996	0.000996	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000995	0.000995	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000966	0.000966	CbGpPWpGaD
Dapiprazole—ADRA1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000951	0.000951	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000945	0.000945	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000942	0.000942	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000942	0.000942	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000904	0.000904	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000904	0.000904	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000881	0.000881	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000876	0.000876	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000863	0.000863	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000858	0.000858	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000849	0.000849	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000826	0.000826	CbGpPWpGaD
Dapiprazole—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000789	0.000789	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000783	0.000783	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000782	0.000782	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000782	0.000782	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00075	0.00075	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000734	0.000734	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000727	0.000727	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000725	0.000725	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000717	0.000717	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000704	0.000704	CbGpPWpGaD
Dapiprazole—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000701	0.000701	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000695	0.000695	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000695	0.000695	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000688	0.000688	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000666	0.000666	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000646	0.000646	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000636	0.000636	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000626	0.000626	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000602	0.000602	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000599	0.000599	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000591	0.000591	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000571	0.000571	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000534	0.000534	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000534	0.000534	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	0.00051	0.00051	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000507	0.000507	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000497	0.000497	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00049	0.00049	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000443	0.000443	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000442	0.000442	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000436	0.000436	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000423	0.000423	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000411	0.000411	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000394	0.000394	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000376	0.000376	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000354	0.000354	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000341	0.000341	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000303	0.000303	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000294	0.000294	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000261	0.000261	CbGpPWpGaD
Dapiprazole—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000243	0.000243	CbGpPWpGaD
Dapiprazole—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000201	0.000201	CbGpPWpGaD
Dapiprazole—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000179	0.000179	CbGpPWpGaD
